TSE:4519Pharmaceuticals
Stronger Q4 Results And Centennial Payout Could Be A Game Changer For Chugai Pharmaceutical (TSE:4519)
Chugai Pharmaceutical reported past fourth-quarter and full-year 2025 results showing higher sales of ¥283,200 million and revenue of ¥346,300 million in the quarter, alongside a planned ¥72 year-end dividend and a ¥75 special year-end dividend per share for approval at the March 2026 AGM.
Alongside these payouts, Chugai reaffirmed its medium-term policy of targeting an average 45% dividend payout ratio versus Core EPS while planning to relocate its head office in 2029 to support its 2030...